Financhill
Back

The Goldman Sachs Group Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
63

GS
The Goldman Sachs Group

Last Price:
$583.54
Seasonality Move:
2.62%
Buy
52

DRUG
Bright Minds Biosciences

Last Price:
$41.55
Seasonality Move:
-32.13%
Buy
63
The Goldman Sachs Group (GS) is a Buy

Is The Goldman Sachs Group a Buy, Sell or Hold?

  • The current The Goldman Sachs Group [GS] share price is $580.13. The Score for GS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Bright Minds Biosciences (DRUG) is a Buy

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GS Stock Price Chart

What is The Goldman Sachs Group's stock price today?

  • The The Goldman Sachs Group share price today is $580.13
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $39.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

GS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 51.78 Buy
Chaikin Money Flow: 832791 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (569.26 - 599.18) Sell
Bollinger Bands (100): (491.61 - 580.55) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 51.96 Buy
Chaikin Money Flow: 6916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.25 - 42.31) Buy
Bollinger Bands (100): (3.23 - 44.21) Buy

GS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 576.53 Buy
20-day SMA: 579.44 Buy
50-day SMA: 574.1 Buy
200-day SMA: 492.61 Buy
8-day EMA: 575.95 Buy
20-day EMA: 578.01 Buy
50-day EMA: 567.97 Buy
200-day EMA: 500.19 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.78 Buy
20-day SMA: 38.82 Buy
50-day SMA: 41.79 Sell
200-day SMA: 12.43 Buy
8-day EMA: 39 Buy
20-day EMA: 39.1 Buy
50-day EMA: 36.05 Buy
200-day EMA: 18.43 Buy

The Goldman Sachs Group Earnings Growth & GS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.12 per share, and an increase next year of $5.50 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

The Goldman Sachs Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):